FDA Approves New Power Morcellator Tissue Containment Device

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

FDA Approves New Power Morcellator Tissue Containment Device

The U.S. Food and Drug Administration (FDA) has announced the approval of a new containment device for use with certain power morcellators.

The PneumoLiner system is designed to effectively isolate and contain uterine tissue not believed to be cancerous that is created by breaking up fibroids during morcellation.

fda actions life cycle bad drug-fda-actions

Because the device has not yet been proven to reduce the spread of potentially cancerous tissue, the FDA is not recommending laparoscopic uterine surgery using power morcellation for the majority of women who require this type of surgery.

The approval comes amid lawsuits alleging that women were put at risk of serious cancer by the use of power morcellators during laparoscopic uterine surgery.

Table of Contents

Power Morcellator Lawsuits Move Forward

Power Morcellator lawsuits continue to be filed on behalf of women who believe the spinning blades of the morcellator spread deadly cancers to their body and worsened their outcome.

What are Power Morcellators?

Power morcellators are used to cut and shred uterine tissue so it can be removed from the body through a small opening during minimally invasive surgical procedures.

But as the morcellator chops up tissue, it disperses this tissue throughout the abdomen, where the cells attach to the intestines or intestinal wall, or spread to other areas of the body.

If the tissue contains cancer cells, morcellation can cause immediate upstaging of the disease, taking it from a potentially treatable Stage 1 cancer to Stage 4 terminal cancer.

The PneumoLiner would contain this tissue and not allow it to be spread throughout the abdomen.

Minimally Invasive Hysterectomies Popular in the U.S.

An estimated 600,000 hysterectomies are performed annually in the U.S., and the FDA first approved power morcellators in 1991, paving the way for doctors to do minimally invasive hysterectomies.

The FDA revised its assessment of the cancer risk associated with morcellation in 2014, estimating that one in every 350 women who undergoes a hysterectomy for fibroids has an undetectable cancer that could potentially be spread by morcellation.

It is estimated that everyday that 2-5 women are exposed to cancerous tissues spread throughout their body as a result of power morcellation – a totally avoidable practice.

Women need to understand these risks before choosing the “minimally invasive” surgery.

PneumoLiner may become an answer in the future, but today, the best answer is to make women aware of the dangers and ban the use of power morcellation.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources